AENT vs FUBO

AENT's Piotroski F-Score of 2/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about default risk, though the company shows strong ROE (20.53%) and recent earnings growth (29.7% YoY). Despite a low valuation multiple (P/E 15.77, P/S 0.32), revenue is declining (-6.3% YoY), and the stock trades below its Graham Number ($4.72) but above its intrinsic value estimate ($12.69), suggesting potential overvaluation relative to growth. Analysts offer no consensus, and insider activity is neutral.

FUBO exhibits critical financial instability, highlighted by a catastrophic Piotroski F-Score of 0/9, indicating failure across all fundamental health metrics. While the Graham Number ($28.49) and Intrinsic Value ($26.88) suggest significant undervaluation relative to the current price of $12.01, these deterministic values are likely decoupled from reality given the company's negative profit margins and liquidity crisis. The massive recent EPS miss (-985.9% surprise) and a current ratio of 0.84 signal high insolvency risk. Despite strong top-line revenue growth, the inability to convert this into operational stability makes the stock a high-risk speculative play rather than a value investment.